GnRH agonist and prasterone/acolbifene

Drug Profile

GnRH agonist and prasterone/acolbifene

Alternative Names: Femitra

Latest Information Update: 02 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Endoceutics
  • Class Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Gonadotropin releasing hormone stimulants; Selective estrogen receptor modulators; Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase III Endometriosis

Most Recent Events

  • 02 Dec 2015 Phase-III development for Endometriosis is ongoing in Canada
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top